Exploring the Potential of Flubendazole in Filariasis Control: Evaluation of the Systemic Exposure for Different Pharmaceutical Preparations

PLoS Neglected Tropical Diseases

Volumn 8, Issue 5, 2014, Pages

  Ceballos, Laura ^a   Mackenzie, Charles ^b   Geary, Timothy ^c   Alvarez, Luis ^a   Lanusse, Carlos ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; FLUBENDAZOLE; OXIBENDAZOLE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ANTINEMATODAL AGENT; BETA CYCLODEXTRIN DERIVATIVE; MEBENDAZOLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CONTROL; DRUG EXPOSURE; DRUG FORMULATION; FILARIASIS; FLOW RATE; GERBIL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF QUANTITATION; NONHUMAN; RAT; SINGLE DRUG DOSE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; MEDICINAL CHEMISTRY; WISTAR RAT;

ANIMALS; ANTINEMATODAL AGENTS; BETA-CYCLODEXTRINS; CARBOXYMETHYLCELLULOSE SODIUM; CHEMISTRY, PHARMACEUTICAL; GERBILLINAE; MEBENDAZOLE; RATS; RATS, WISTAR;

EID: 84901815702     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002838     Document Type: Article

References (37)

1. WHO. (2010) First WHO report on neglected tropical diseases 2010: Working to overcome the global impact of neglected tropical diseases. Geneva: World Health Organization.
2. Taylor MJ, Hoerauf A, Bockarie M, (2010) Lymphatic filariasis and onchocerciasis. Lancet 376: 1175-85.
3. Longo M, Zanoncelli S, Colombo PA, Harhay MO, Scandale I, et al. (2013) Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro. Reprod Toxicol 36: 78-87.
4. Hopkins AD, (2005) Ivermectin and onchocerciasis: is it all solved? Eye (Lond.) 19: 1057-1066.
5. Geary TG, Woo K, McCarthy JS, et al. (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40: 1-13.
6. Mackenzie CD, Geary TG, (2011) Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Expert Rev Anti Infect Ther 5: 497-501.
7. Geary TG, (2012) Are new anthelmintics needed to eliminate human helminthiases? Curr Opin Infect Dis 25: 709-17.
8. Zahner H, Schares G, (1993) Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Trop 52: 221-66.
9. EMEA (1997) EMEA/MRL/267/97-FINAL. The European Agency for the Evaluation of Medicinal Products. Flubendazol, Summary Report 2. Veterinary Medicines Evaluation Unit, Committee for Veterinary Medicinal Products, London, UK. http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500014288.pdf.
10. Moreno L, Alvarez L, Mottier L, Virkel G, Sanchez Bruni S, et al. (2004) Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite difussion ability. J Vet Pharmacol Ther 27: 299-308.
11. Denham DA, (1979) A review of methods for testing compounds for filaricidal activity. J Helminthol 53: 175-87.
12. Dominguez-Vazquez A, Taylor H, Greene B, Ruvalcaba Macias A, Rivas-Alcalá A, et al. (1983) Comparison of flubendazole and diethylcarbamazine in the treatment of onchocerciasis. Lancet 321: 139-143.
13. Edwards G, Breckenridge A, (1988) Clinical pharmacokinetics of anthelmintic drugs. Clin Pharmacokinet 15: 67-93.
14. Frömming K, Szejtli J (1994) Cyclodextrins in pharmacy. Kluwer Academic Publishers, Dordrecht, The Netherlands.
15. Loftsson T, Duchene D, (2007) Historical Perspectives. Cyclodextrins and their pharmaceutical applications. Int J Pharm 329: 1-11.
16. Ceballos L, Moreno L, Torrado J, Lanusse C, Alvarez L, (2012a) Evaluation of flubendazole formulations for use in sheep. Pharmacokinetic assessment of a cyclodextrin-based solution. BMC Vet Res 1: 71.
17. Ceballos L, Elissondo C, Sánchez Bruni S, Denegri G, et al. (2009) Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice. Parasitol Int 58: 354-358.
18. García J, Bolás F, Torrado JJ, (2003) Int J Pharm 250: 351-8.
19. Rigter IM, Schipper HG, Koopmans RP, van Kan HJ, Frijlink HW, et al. (2004) Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. Antimicrob Agents Chemother 48: 1051-1054.
20. Guide for the Care and Use of Laboratory Animals. Editors. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Source 8th edition. Washington (DC): National Academies Press (US); 2011. The National Academies Collection: Reports funded by National Institutes of Health.
21. Gibaldi M, Perrier D (1982) Pharmacokinetics. 2nd edn., Revised and Expanded. pp. 45-109. Marcel Dekker, New York, NY, USA.
22. Lanusse CE, Prichard RK, (1993) Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab Rev 25: 235-79.
23. Thompson D, Ho N, Sims S, Geary T, (1993) Mechanistic approaches to quantitate anthelmintic absorption by gastrointestinal nematodes. Parasitol Today 9: 31-35.
24. Alvarez L, Lifschitz A, Entrocasso C, Manazza J, Mottier L, et al. (2008) Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. J Vet Pharmacol Ther 31: 230-9.
25. Wu Z, Tucker I, Razzak M, Yang L, McSporran K, et al. (2010) Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-cyclodextrin following subcutaneous injection in sheep. Int J Pharm 397: 96-102.
26. Lanusse CE, Ranjan S, Prichard RK, (1990) Comparison of pharmacokinetic variables for two injectable formulations of netobimin administered to calves. Am J Vet Res 51: 1459-63.
27. MacKellar Q, Scott E, (1990) The benzimidazole anthelmintcs agents-a review. J Vet Pharm Ther 13: 223-247.
28. Rodrigues J, Bories C, Emery I, Fessi H, Devissaguet J, et al. (1995) Development of an injectable formulation of ABZ and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode. Int J Parasitol 25: 1437-1441.
29. Daniel-Mwambete K, Torrado S, Cuesta-Bandera C, Ponce-Gordo F, Torrado JJ, (2004) The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 272: 29-36.
30. Ceballos L, Elissondo C, Sanchez Bruni S, Denegri G, Lanusse C, et al. (2011) Comparative performance of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cysts disposition and efficacy in infected mice. Antimicrob Agents chemother 55: 5861-7.
31. Masson M, Loftsson T, Masson G, Stefansson E, (1999) Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release 59: 107-118.
32. Galtier P, Alvinerie M, Delatour P, (1986) In vitro sulfoxidation of albendazole by ovine liver microsomes: assay and frequency of various xenobiotics. Am J Vet Res 47: 447-450.
33. Virkel G, Lifschitz A, Sallovitz J, Pis A, Lanusse C, (2004) Comparative hepatic and extrahepatic enantioselective sulphoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab Dispos 32: 536-544.
34. Maté L, Virkel G, Lifschitz A, Ballent M, Lanusse C, (2008) Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep. Biochem Pharmacol 76: 773-783.
35. Ceballos L, Alvarez L, Moreno L, MacKenzie C, Geary T, et al. (2012b) Development of Flubendazole as a Macrofilaricide Compound-Systemic Exposure in Pigs Treated with Different Formulations-. 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology, Amsterdam, Holland.
36. Alvarez L, et al. (2009) Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Vet. Parasitol 164: 211-216.
37. Urbizu L, Confalonieri A, Sánchez Bruni S, Lanusse C, Alvarez L, (2012) Nematodicidal activity of flubendazole and its reduced metabolite on a murine model of Trichinella spiralis infection. Chemotherapy 58: 295-8.